1 North Wealth Services’s Pacira BioSciences PCRX Stock Holding History

1 North Wealth Services’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.16K	Hold	85	–	–	﹤0.01%	277
2026 Q1	$1.92K	Hold	85	–	–	﹤0.01%	241
2025 Q4	$2.2K	Hold	85	–	–	﹤0.01%	247
2025 Q3	$2.19K	Hold	85	–	–	﹤0.01%	228
2025 Q2	$2.03K	Sell	85 -80	-48%	-$2.02K	﹤0.01%	232
2025 Q1	$4.1K	Buy	+165	New	+$3.95K	﹤0.01%	196

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

1 North Wealth Services's PCRX Position: Q2 2026 in Review

1 North Wealth Services held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 85 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #277.

1 North Wealth Services first reported a position in PCRX in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.1K in Q1 2025. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

1 North Wealth Services held 85 shares of Pacira BioSciences worth $2.16K as of Q2 2026.
1 North Wealth Services left its Pacira BioSciences share count unchanged in Q2 2026.
Pacira BioSciences made up ﹤0.01% of 1 North Wealth Services's portfolio in Q2 2026, its #277 holding.
1 North Wealth Services first reported a position in Pacira BioSciences in Q1 2025 and has held it in 6 quarters since.
1 North Wealth Services's Pacira BioSciences position peaked at $4.1K in Q1 2025.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on 1 North Wealth Services's 13F filing for Q2 2026, filed 3 Aug 2026.